![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1660-3818|39|2|98-103
ISSN: 1660-3796
Source: Transfusion Medicine and Hemotherapy, Vol.39, Iss.2, 2012-03, pp. : 98-103
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Factors affecting patient‐reported outcomes after red blood cell transfusion in medical patients
TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eculizumab inhibits hemolysis in a model of ABO‐incompatible red blood cell transfusion
TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Increased hospital costs associated with red blood cell transfusion
TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Red blood cell transfusion in adult palliative care: a systematic review
TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. :